RSNA (Radiological Society of North America) showcases developments to open up new horizons
This article was originally published in Clinica
The Radiological Society of North America meeting this year, aptly located within the vast, apparently limitless precincts of McCormick Place in Chicago, was again an impressive showcase for commercial and academic representatives alike. Some of the cutting-edge radiological technologies and innovative research profiled at the event, in November, have been featured in recent issues of Clinica. This is the fourth and final report on the meeting.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.